As of August 2022 Halozyme Therapeutics has a market cap of $5.96 Billion. This makes Halozyme Therapeutics the world's 2108th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $5.96 B | 5.32% |
2021 | $5.66 B | -1.95% |
2020 | $5.77 B | 138.2% |
2019 | $2.42 B | 14.48% |
2018 | $2.11 B | -26.59% |
2017 | $2.88 B | 125.44% |
2016 | $1.27 B | -42.39% |
2015 | $2.22 B | 83.06% |
2014 | $1.21 B | -29.34% |
2013 | $1.71 B | 127.01% |
2012 | $0.75 B | -23.31% |
2011 | $0.98 B | 23.79% |
2010 | $0.79 B | 48.02% |
2009 | $0.53 B | 18% |
2008 | $0.45 B | -17.66% |
2007 | $0.55 B | 0.1% |
2006 | $0.55 B | 404.64% |
2005 | $0.10 B | 1.3% |
2004 | $0.10 B |
On Aug 9th, 2022 the market cap of Halozyme Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $447.01 B | 7,397.46% | ๐บ๐ธ USA |
![]() Pfizer PFE | $277.57 B | 4,555.52% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $288.65 B | 4,741.40% | ๐บ๐ธ USA |
![]() Sanofi SNY | $111.16 B | 1,764.48% | ๐ซ๐ท France |
![]() Baxter BAX | $30.19 B | 406.47% | ๐บ๐ธ USA |
![]() MannKind Corp MNKD | $1.04 B | -82.44% | ๐บ๐ธ USA |